Identification Generic Name (1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid DrugBank Accession Number DB03121 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid (DB03121) ×  Close Weight Average: 309.3591  Monoisotopic: 309.136493479  Chemical Formula C 19 H 19 NO 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Phospholipase A2, membrane associated Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Indoles and derivatives Sub Class Indolyl carboxylic acids and derivatives Direct Parent Indole-3-acetic acid derivatives Alternative Parents N-alkylindoles  /  3-alkylindoles  /  Anisoles  /  Alkyl aryl ethers  /  Substituted pyrroles  /  Benzene and substituted derivatives  /  Heteroaromatic compounds  /  Monocarboxylic acids and derivatives  /  Carboxylic acids  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 5 more Substituents 3-alkylindole  /  Alkyl aryl ether  /  Anisole  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Carbonyl group  /  Carboxylic acid  /  Carboxylic acid derivative  /  Ether  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Indole  /  Indole-3-acetic acid derivative  /  Monocarboxylic acid or derivatives  /  Monocyclic benzene moiety  /  N-alkylindole  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Pyrrole  /  Substituted pyrrole 
 
 
  show 15 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number 59283-35-1 InChI Key ZEKCBTQHDTUHRJ-UHFFFAOYSA-N InChI InChI=1S/C19H19NO3/c1-13-16(11-19(21)22)17-10-15(23-2)8-9-18(17)20(13)12-14-6-4-3-5-7-14/h3-10H,11-12H2,1-2H3,(H,21,22) IUPAC Name 2-(1-benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid SMILES COC1=CC2=C(C=C1)N(CC1=CC=CC=C1)C(C)=C2CC(O)=O References General References Not Available External Links PubChem Compound 1372 PubChem Substance 46505875 ChemSpider 1331 BindingDB 50055737 ChEMBL CHEMBL148756 ZINC ZINC000001685326 PDBe Ligand I3N PDB Entries 1dcy Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0101 mg/mL ALOGPS logP 3.82 ALOGPS logP 3.7 Chemaxon logS -4.5 ALOGPS pKa (Strongest Acidic) 4.43 Chemaxon pKa (Strongest Basic) -4.8 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 51.46 Å 2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 89.57 m 3 ·mol -1 Chemaxon Polarizability 33.54 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9956 Blood Brain Barrier + 0.9693 Caco-2 permeable + 0.7814 P-glycoprotein substrate Non-substrate 0.5087 P-glycoprotein inhibitor I Non-inhibitor 0.7332 P-glycoprotein inhibitor II Non-inhibitor 0.6728 Renal organic cation transporter Non-inhibitor 0.5469 CYP450 2C9 substrate Non-substrate 0.7492 CYP450 2D6 substrate Non-substrate 0.5889 CYP450 3A4 substrate Substrate 0.5764 CYP450 1A2 substrate Inhibitor 0.8883 CYP450 2C9 inhibitor Non-inhibitor 0.5897 CYP450 2D6 inhibitor Non-inhibitor 0.8141 CYP450 2C19 inhibitor Inhibitor 0.7365 CYP450 3A4 inhibitor Non-inhibitor 0.5916 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7091 Ames test Non AMES toxic 0.6564 Carcinogenicity Non-carcinogens 0.9429 Biodegradation Not ready biodegradable 0.9521 Rat acute toxicity 2.6349 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9359 hERG inhibition (predictor II) Non-inhibitor 0.7355    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 13600 N/A N/A A30104 
 
 
  Details 
 
 
   Binding Properties 1.  Phospholipase A2, membrane associated Kind Protein Organism Humans Pharmacological action Unknown General Function Phospholipid binding Specific Function Thought to participate in the regulation of the phospholipid metabolism in biomembranes including eicosanoid biosynthesis. Catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-ph... Gene Name PLA2G2A Uniprot ID P14555 Uniprot Name Phospholipase A2, membrane associated Molecular Weight 16082.525 Da References Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [ Article ]  Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [ Article ]  Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 